Related Experiment Video
Updated: Oct 24, 2025
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Clinical Experience, Characteristics, and Performance of an Acetaminophen Absorption Test in Critically Ill Patients
Molly E Droege1, Abigail G Rhoades2, Christopher A Droege1
1UC Health-University of Cincinnati Medical Center, University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, OH.
Background:
Altered drug and nutrient absorption presents a unique challenge in critically ill patients. Performing an acetaminophen absorption test (AAT) has been used as a marker for gastric motility and upper small bowel absorption; thus, it may provide objective data regarding enteral absorptive ability in critically ill patients.
Study Question:
What is the clinical experience with AAT when used as a surrogate marker for enteral absorption in critically ill patients?
Study Design:
This single-center, retrospective, cohort study evaluated serum acetaminophen concentrations within 180 minutes following 1-time enteral administration of an AAT. Patients admitted to the surgical and medical intensive care units and medical intensive care units over a 7-year period were evaluated. Groups were defined as positive (acetaminophen concentration of ≥10 mg/L) or negative (acetaminophen concentration of <10 mg/L) AAT.
Measures And Outcomes:
The outcomes were to describe the clinical experience, characteristics, and performance of AAT.
Results:
Forty-eight patients were included. Patients were 58.5 ± 14 years of age, mostly male (58.3%), and admitted to the surgical intensive care unit (66.7%). Median hospital length of stay was 47.5 (27-78.8) days. Thirty-four patients (70.8%) had a positive AAT [median concentration, 14 (12-18) mg/L]. Median time to first detectable concentration was 37 (33-64) minutes. AAT characteristics were similar between the groups including total dose, weight-based dose, time to first and second assays, drug formulation, and site of administration between groups. There were no independent risk factors identified on regression analysis for negative AAT.
Conclusions:
An acetaminophen dose of 15 mg/kg with 2 coordinated serum concentrations approximately 30 and 60 minutes after administration is a reasonable construct for AAT. Future research is needed to assess AAT utility, safety, and clinical outcomes for predicting patient ability to absorb enteral feeds and medications.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:30Measurement of Bioavailability: Pharmacokinetic Methods
01:09Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...